4
Changes in Ownership
TransMedics Group, Inc. Filed Acc 0000950170-24-084297
President & CEO sold 8,625 shares at an average $145.17 ($1,252,051)
- President & CEO acquired 8,625 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Hassanein Waleed H · President & CEO
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-07-15 | Exercise or conversion : show line 1 in the form 10b5-1 | +8,625 | $13.28 | $114,540 | 70,268 | D |
| 2024-07-15 | Sale : show line 2 in the form 10b5-1 | −1,397 | $143.61 | $200,623 | 68,871 | D |
| 2024-07-15 | Sale : show line 3 in the form 10b5-1 | −2,540 | $144.34 | $366,624 | 66,331 | D |
| 2024-07-15 | Sale : show line 4 in the form 10b5-1 | −2,046 | $145.54 | $297,775 | 64,285 | D |
| 2024-07-15 | Sale : show line 5 in the form 10b5-1 | −2,342 | $146.39 | $342,845 | 61,943 | D |
| 2024-07-15 | Sale : show line 6 in the form 10b5-1 | −300 | $147.28 | $44,184 | 61,643 | D |
| Open-market sales · 8,625 sh · avg $145.17 · $1,252,051 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-07-15 | Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (Right to Buy) | −8,625 | 122,125 | D |
Loading xslF345X05/ownership.xml…